NeoGenomics (NEO) Competitors $7.62 +0.22 (+2.91%) Closing price 07/3/2025 03:52 PM EasternExtended Trading$7.62 0.00 (0.00%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEO vs. TNET, CARG, CNXC, DLO, PAGS, ATHM, ALIT, CLVT, WNS, and FAShould you be buying NeoGenomics stock or one of its competitors? The main competitors of NeoGenomics include TriNet Group (TNET), CarGurus (CARG), Concentrix (CNXC), DLocal (DLO), PagSeguro Digital (PAGS), Autohome (ATHM), Alight (ALIT), Clarivate (CLVT), WNS (WNS), and First Advantage (FA). These companies are all part of the "business services" industry. NeoGenomics vs. Its Competitors TriNet Group CarGurus Concentrix DLocal PagSeguro Digital Autohome Alight Clarivate WNS First Advantage NeoGenomics (NASDAQ:NEO) and TriNet Group (NYSE:TNET) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership. Do analysts prefer NEO or TNET? NeoGenomics presently has a consensus target price of $13.83, suggesting a potential upside of 81.66%. TriNet Group has a consensus target price of $96.67, suggesting a potential upside of 30.00%. Given NeoGenomics' stronger consensus rating and higher possible upside, analysts clearly believe NeoGenomics is more favorable than TriNet Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeoGenomics 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45TriNet Group 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Is NEO or TNET more profitable? TriNet Group has a net margin of 3.32% compared to NeoGenomics' net margin of -11.54%. TriNet Group's return on equity of 237.87% beat NeoGenomics' return on equity.Company Net Margins Return on Equity Return on Assets NeoGenomics-11.54% -2.21% -1.22% TriNet Group 3.32%237.87%5.60% Does the media favor NEO or TNET? In the previous week, NeoGenomics had 4 more articles in the media than TriNet Group. MarketBeat recorded 6 mentions for NeoGenomics and 2 mentions for TriNet Group. NeoGenomics' average media sentiment score of 0.00 equaled TriNet Group'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeoGenomics 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TriNet Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation and earnings, NEO or TNET? TriNet Group has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than TriNet Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeoGenomics$660.57M1.48-$78.73M-$0.61-12.48TriNet Group$5.05B0.71$173M$3.3522.20 Do insiders and institutionals hold more shares of NEO or TNET? 98.5% of NeoGenomics shares are owned by institutional investors. Comparatively, 96.8% of TriNet Group shares are owned by institutional investors. 2.4% of NeoGenomics shares are owned by insiders. Comparatively, 38.1% of TriNet Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more risk & volatility, NEO or TNET? NeoGenomics has a beta of 1.63, indicating that its share price is 63% more volatile than the S&P 500. Comparatively, TriNet Group has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. SummaryTriNet Group beats NeoGenomics on 8 of the 15 factors compared between the two stocks. Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEO vs. The Competition Export to ExcelMetricNeoGenomicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$971.64M$2.89B$5.53B$9.04BDividend YieldN/A2.44%5.24%4.02%P/E Ratio-12.4821.7127.6320.25Price / Sales1.48281.07417.36118.60Price / Cash17.2142.7336.8958.07Price / Book1.087.518.035.67Net Income-$78.73M-$55.14M$3.18B$249.21M7 Day Performance6.06%4.61%2.91%3.28%1 Month Performance6.80%4.72%3.72%5.55%1 Year Performance-43.92%5.92%35.14%21.08% NeoGenomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEONeoGenomics3.6737 of 5 stars$7.62+2.9%$13.83+81.7%-44.5%$971.64M$660.57M-12.482,100TNETTriNet Group3.9379 of 5 stars$73.25+0.8%$96.67+32.0%-25.1%$3.55B$5.05B21.873,600Positive NewsEx-DividendCARGCarGurus4.4962 of 5 stars$33.47+0.6%$36.95+10.4%+38.4%$3.49B$903.75M95.631,282Trending NewsAnalyst DowngradeInsider TradeCNXCConcentrix4.7016 of 5 stars$52.85+2.2%$66.75+26.3%-14.4%$3.38B$9.62B14.52450,000DLODLocal1.6938 of 5 stars$11.34-1.2%$12.45+9.8%+43.6%$3.24B$745.97M23.141,095PAGSPagSeguro Digital3.4986 of 5 stars$9.64+2.7%$11.63+20.6%-21.2%$3.18B$18.84B7.908,595Positive NewsATHMAutohome3.3247 of 5 stars$25.84-0.3%$32.00+23.8%-4.9%$3.10B$6.88B14.284,415News CoverageALITAlight4.5561 of 5 stars$5.67+1.8%$9.86+73.8%-15.8%$3.05B$2.33B-40.509,500News CoveragePositive NewsOptions VolumeCLVTClarivate2.0979 of 5 stars$4.32+0.2%$5.00+15.7%-22.4%$2.95B$2.56B-4.4512,000Insider TradeWNSWNS1.4468 of 5 stars$63.41+4.9%$62.25-1.8%+21.6%$2.94B$1.31B17.0564,505High Trading VolumeFAFirst Advantage2.4551 of 5 stars$16.61+5.1%$66.00+297.4%+6.3%$2.88B$1.05B553.675,500Positive News Related Companies and Tools Related Companies TriNet Group Alternatives CarGurus Alternatives Concentrix Alternatives DLocal Alternatives PagSeguro Digital Alternatives Autohome Alternatives Alight Alternatives Clarivate Alternatives WNS Alternatives First Advantage Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEO) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
